# Zambia Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Zambia HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Zambia (ZMB)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $80.0M
- Products: 15
- Buyer markets: 23
- Average CAGR: +37.0%
- Global sector size: $220.7B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $116.0B | $716.8K | $56.3B | -5.3% | 11 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $22.6B | $32.1M | $13.2B | +28.6% | 8 | +0.1% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $28.8B | $57.2K | $10.8B | +33.2% | 13 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $21.7B | $2.8K | $9.1B | +6.1% | 10 | +0.0% |
| HS 282200 - Cobalt oxides and hydroxides: commercial cobalt oxides | $4.1B | $46.9M | $7.6B | +46.5% | 2 | +1.4% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $9.9B | $24.7 | $4.7B | +11.3% | 2 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $5.7B | $2.5K | $3.1B | +19.2% | 5 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $5.2B | $61.8K | $2.5B | +10.5% | 4 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $3.0B | $9.0K | $2.0B | +0.9% | 1 | +0.0% |
| HS 382319 - Industrial monocarboxylic fatty acids: acid oils from refining: (other than stearic acid, oleic acid or tall oil fatty acids) | $1.3B | $98.5K | $1.9B | +1074.1% | 1 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $529.8M | $127.6 | $535.0M | -2.4% | 1 | +0.0% |
| HS 340130 - Organic surface-active products and preparations for washing the skin, in the form of liquid or cream and put up for retail sale, whether or not containing soap | $735.1M | $436.6 | $479.5M | +293.8% | 1 | +0.0% |
| HS 340319 - Lubricating preparations: (other than for the treatment of textile and similar materials), containing less than 70% (by weight) of petroleum oils or oils obtained from bituminous minerals | $371.3M | $29.1 | $457.6M | -77.8% | 1 | +0.0% |
| HS 370790 - Photographic goods: chemical preparations other than sensitised emulsions, put up in measured portions or put up for retail sale in a form ready for use | $478.9M | $713.5 | $380.9M | +11.5% | 1 | +0.0% |
| HS 321410 - Mastics: painters' fillings | $374.0M | $261.4 | $368.2M | +75.3% | 1 | +0.0% |

## Best markets

- Switzerland, Liechtenstein (CHE): $27.7B calculated opportunity across 1 products.
- China (CHN): $14.0B calculated opportunity across 5 products.
- USA, Puerto Rico and US Virgin Islands (USA): $13.9B calculated opportunity across 6 products.
- United Kingdom (GBR): $10.9B calculated opportunity across 7 products.
- Canada (CAN): $8.1B calculated opportunity across 7 products.
- Netherlands (NLD): $7.5B calculated opportunity across 5 products.
- Belgium (BEL): $7.0B calculated opportunity across 1 products.
- France (FRA): $5.5B calculated opportunity across 6 products.
- Germany (DEU): $4.6B calculated opportunity across 4 products.
- South Africa (ZAF): $4.5B calculated opportunity across 4 products.
- Ireland (IRL): $3.5B calculated opportunity across 2 products.
- United Arab Emirates (ARE): $1.2B calculated opportunity across 3 products.

## Growth stars

- HS 382319: +1074.1% average CAGR, $1.9B calculated opportunity.
- HS 340130: +293.8% average CAGR, $479.5M calculated opportunity.
- HS 321410: +75.3% average CAGR, $368.2M calculated opportunity.
- HS 282200: +46.5% average CAGR, $7.6B calculated opportunity.
- HS 330499: +33.2% average CAGR, $10.8B calculated opportunity.
- HS 382499: +28.6% average CAGR, $13.2B calculated opportunity.
- HS 300290: +19.2% average CAGR, $3.1B calculated opportunity.
- HS 370790: +11.5% average CAGR, $380.9M calculated opportunity.
- HS 300212: +11.3% average CAGR, $4.7B calculated opportunity.
- HS 330300: +10.5% average CAGR, $2.5B calculated opportunity.

## Diversification opportunities

- HS 330499: 13 buyer markets, $10.8B calculated opportunity.
- HS 300490: 11 buyer markets, $56.3B calculated opportunity.
- HS 382200: 10 buyer markets, $9.1B calculated opportunity.
- HS 382499: 8 buyer markets, $13.2B calculated opportunity.
- HS 300290: 5 buyer markets, $3.1B calculated opportunity.
- HS 330300: 4 buyer markets, $2.5B calculated opportunity.
- HS 282200: 2 buyer markets, $7.6B calculated opportunity.
- HS 300212: 2 buyer markets, $4.7B calculated opportunity.
- HS 300439: 1 buyer markets, $2.0B calculated opportunity.
- HS 382319: 1 buyer markets, $1.9B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.